Report Detail
Global (United States, European Union and China) Insulin Delivery Systems Market Research Report 2019-2025
- RnM3666077 |
- 13 August, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Other
An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin therapy. The device configuration may vary depending on design. A traditional pump includes: the pump (including controls, processing module, and batteries), a disposable reservoir for insulin (inside the pump) and a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to connect the insulin reservoir to the cannula.
An insulin pump is an alternative to multiple daily injections of insulin by insulin syringes or an insulin pen and allows for flexible insulin therapy when used in conjunction with blood glucose monitoring and carbohydrate counting.
In 2019, the market size of Insulin Delivery Systems is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Insulin Delivery Systems.
This report studies the global market size of Insulin Delivery Systems, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Insulin Delivery Systems production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Becton, Dickinson and Company
Novo Nordisk
Medtronic
Sanofi
ELI Lilly and Company
Ypsomed Holding
Animas Corporation
Tandem Diabetes Care
Insulet Corporation
Biocon
Market Segment by Product Type
Pens
Pumps
Pen Needles
Syringes
Market Segment by Application
Patients/Homecare
Hospitals & Clinics
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Insulin Delivery Systems status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Insulin Delivery Systems manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Insulin Delivery Systems are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Research Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Insulin Delivery Systems Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Pens
- 1.3.3 Pumps
- 1.3.4 Pen Needles
- 1.3.5 Syringes
- 1.4 Market Segment by Application
- 1.4.1 Global Insulin Delivery Systems Market Share by Application (2019-2025)
- 1.4.2 Patients/Homecare
- 1.4.3 Hospitals & Clinics
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Production and Capacity Analysis
- 2.1.1 Global Insulin Delivery Systems Production Value 2014-2025
- 2.1.2 Global Insulin Delivery Systems Production 2014-2025
- 2.1.3 Global Insulin Delivery Systems Capacity 2014-2025
- 2.1.4 Global Insulin Delivery Systems Marketing Pricing and Trends
- 2.2 Key Producers Growth Rate (CAGR) 2019-2025
- 2.2.1 Global Insulin Delivery Systems Market Size CAGR of Key Regions
- 2.2.2 Global Insulin Delivery Systems Market Share of Key Regions
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Capacity and Production by Manufacturers
- 3.1.1 Global Insulin Delivery Systems Capacity by Manufacturers
- 3.1.2 Global Insulin Delivery Systems Production by Manufacturers
- 3.2 Revenue by Manufacturers
- 3.2.1 Insulin Delivery Systems Revenue by Manufacturers (2014-2019)
- 3.2.2 Insulin Delivery Systems Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Insulin Delivery Systems Market Concentration Ratio (CR5 and HHI)
- 3.3 Insulin Delivery Systems Price by Manufacturers
- 3.4 Key Manufacturers Insulin Delivery Systems Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Insulin Delivery Systems Market
- 3.6 Key Manufacturers Insulin Delivery Systems Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Production and Production Value for Each Type
- 4.1.1 Pens Production and Production Value (2014-2019)
- 4.1.2 Pumps Production and Production Value (2014-2019)
- 4.1.3 Pen Needles Production and Production Value (2014-2019)
- 4.1.4 Syringes Production and Production Value (2014-2019)
- 4.2 Global Insulin Delivery Systems Production Market Share by Type
- 4.3 Global Insulin Delivery Systems Production Value Market Share by Type
- 4.4 Insulin Delivery Systems Ex-factory Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Insulin Delivery Systems Consumption by Application
6 Production by Regions
- 6.1 Global Insulin Delivery Systems Production (History Data) by Regions 2014-2019
- 6.2 Global Insulin Delivery Systems Production Value (History Data) by Regions
- 6.3 United States
- 6.3.1 United States Insulin Delivery Systems Production Growth Rate 2014-2019
- 6.3.2 United States Insulin Delivery Systems Production Value Growth Rate 2014-2019
- 6.3.3 Key Players in United States
- 6.3.4 United States Insulin Delivery Systems Import & Export
- 6.4 European Union
- 6.4.1 European Union Insulin Delivery Systems Production Growth Rate 2014-2019
- 6.4.2 European Union Insulin Delivery Systems Production Value Growth Rate 2014-2019
- 6.4.3 Key Players in European Union
- 6.4.4 European Union Insulin Delivery Systems Import & Export
- 6.5 China
- 6.5.1 China Insulin Delivery Systems Production Growth Rate 2014-2019
- 6.5.2 China Insulin Delivery Systems Production Value Growth Rate 2014-2019
- 6.5.3 Key Players in China
- 6.5.4 China Insulin Delivery Systems Import & Export
- 6.6 Rest of World
- 6.6.1 Japan
- 6.6.2 Korea
- 6.6.3 India
- 6.6.4 Southeast Asia
7 Insulin Delivery Systems Consumption by Regions
- 7.1 Global Insulin Delivery Systems Consumption (History Data) by Regions
- 7.2 United States
- 7.2.1 United States Insulin Delivery Systems Consumption by Type
- 7.2.2 United States Insulin Delivery Systems Consumption by Application
- 7.3 European Union
- 7.3.1 European Union Insulin Delivery Systems Consumption by Type
- 7.3.2 European Union Insulin Delivery Systems Consumption by Application
- 7.4 China
- 7.4.1 China Insulin Delivery Systems Consumption by Type
- 7.4.2 China Insulin Delivery Systems Consumption by Application
- 7.5 Rest of World
- 7.5.1 Rest of World Insulin Delivery Systems Consumption by Type
- 7.5.2 Rest of World Insulin Delivery Systems Consumption by Application
- 7.5.1 Japan
- 7.5.2 Korea
- 7.5.3 India
- 7.5.4 Southeast Asia
8 Company Profiles
- 8.1 Becton, Dickinson and Company
- 8.1.1 Becton, Dickinson and Company Company Details
- 8.1.2 Company Description and Business Overview
- 8.1.3 Production and Revenue of Insulin Delivery Systems
- 8.1.4 Insulin Delivery Systems Product Introduction
- 8.1.5 Becton, Dickinson and Company Recent Development
- 8.2 Novo Nordisk
- 8.2.1 Novo Nordisk Company Details
- 8.2.2 Company Description and Business Overview
- 8.2.3 Production and Revenue of Insulin Delivery Systems
- 8.2.4 Insulin Delivery Systems Product Introduction
- 8.2.5 Novo Nordisk Recent Development
- 8.3 Medtronic
- 8.3.1 Medtronic Company Details
- 8.3.2 Company Description and Business Overview
- 8.3.3 Production and Revenue of Insulin Delivery Systems
- 8.3.4 Insulin Delivery Systems Product Introduction
- 8.3.5 Medtronic Recent Development
- 8.4 Sanofi
- 8.4.1 Sanofi Company Details
- 8.4.2 Company Description and Business Overview
- 8.4.3 Production and Revenue of Insulin Delivery Systems
- 8.4.4 Insulin Delivery Systems Product Introduction
- 8.4.5 Sanofi Recent Development
- 8.5 ELI Lilly and Company
- 8.5.1 ELI Lilly and Company Company Details
- 8.5.2 Company Description and Business Overview
- 8.5.3 Production and Revenue of Insulin Delivery Systems
- 8.5.4 Insulin Delivery Systems Product Introduction
- 8.5.5 ELI Lilly and Company Recent Development
- 8.6 Ypsomed Holding
- 8.6.1 Ypsomed Holding Company Details
- 8.6.2 Company Description and Business Overview
- 8.6.3 Production and Revenue of Insulin Delivery Systems
- 8.6.4 Insulin Delivery Systems Product Introduction
- 8.6.5 Ypsomed Holding Recent Development
- 8.7 Animas Corporation
- 8.7.1 Animas Corporation Company Details
- 8.7.2 Company Description and Business Overview
- 8.7.3 Production and Revenue of Insulin Delivery Systems
- 8.7.4 Insulin Delivery Systems Product Introduction
- 8.7.5 Animas Corporation Recent Development
- 8.8 Tandem Diabetes Care
- 8.8.1 Tandem Diabetes Care Company Details
- 8.8.2 Company Description and Business Overview
- 8.8.3 Production and Revenue of Insulin Delivery Systems
- 8.8.4 Insulin Delivery Systems Product Introduction
- 8.8.5 Tandem Diabetes Care Recent Development
- 8.9 Insulet Corporation
- 8.9.1 Insulet Corporation Company Details
- 8.9.2 Company Description and Business Overview
- 8.9.3 Production and Revenue of Insulin Delivery Systems
- 8.9.4 Insulin Delivery Systems Product Introduction
- 8.9.5 Insulet Corporation Recent Development
- 8.10 Biocon
- 8.10.1 Biocon Company Details
- 8.10.2 Company Description and Business Overview
- 8.10.3 Production and Revenue of Insulin Delivery Systems
- 8.10.4 Insulin Delivery Systems Product Introduction
- 8.10.5 Biocon Recent Development
9 Market Forecast
- 9.1 Global Market Size Forecast
- 9.1.1 Global Insulin Delivery Systems Capacity, Production Forecast 2019-2025
- 9.1.2 Global Insulin Delivery Systems Production Value Forecast 2019-2025
- 9.2 Market Forecast by Regions
- 9.2.1 Global Insulin Delivery Systems Production and Value Forecast by Regions 2019-2025
- 9.2.2 Global Insulin Delivery Systems Consumption Forecast by Regions 2019-2025
- 9.3 United States
- 9.3.1 Production and Value Forecast in United States
- 9.3.2 Consumption Forecast in United States
- 9.4 European Union
- 9.4.1 Production and Value Forecast in European Union
- 9.4.2 Consumption Forecast in European Union
- 9.5 China
- 9.5.1 Production and Value Forecast in China
- 9.5.2 Consumption Forecast in China
- 9.6 Rest of World
- 9.6.1 Japan
- 9.6.2 Korea
- 9.6.3 India
- 9.6.4 Southeast Asia
- 9.7 Forecast by Type
- 9.7.1 Global Insulin Delivery Systems Production Forecast by Type
- 9.7.2 Global Insulin Delivery Systems Production Value Forecast by Type
- 9.8 Consumption Forecast by Application
10 Value Chain and Sales Channels Analysis
- 10.1 Value Chain Analysis
- 10.2 Sales Channels Analysis
- 10.2.1 Insulin Delivery Systems Sales Channels
- 10.2.2 Insulin Delivery Systems Distributors
- 10.3 Insulin Delivery Systems Customers
11 Opportunities & Challenges, Threat and Affecting Factors
- 11.1 Market Opportunities
- 11.2 Market Challenges
- 11.3 Porter's Five Forces Analysis
12 Key Findings
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.1.1 Research Programs/Design
- 13.1.1.2 Market Size Estimation
- 13.1.1.3 Market Breakdown and Data Triangulation
- 13.1.2 Data Source
- 13.1.2.1 Secondary Sources
- 13.1.2.2 Primary Sources
- 13.1.1 Methodology/Research Approach
- 13.2 Author Details
Summary:
Get latest Market Research Reports on InsulinDeliverySystems. Industry analysis & Market Report on InsulinDeliverySystems is a syndicated market report, published as Global (United States, European Union and China) Insulin Delivery Systems Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of InsulinDeliverySystems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
